Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01241604 · ClinicalTrials.gov registry record · NA
Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device Compared to BiPAP S/T Device
A NA study, sponsored by Philips Respironics.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01241604: Clinical Trial NA study, sponsored by Philips Respironics.
NCT01241604 is a NA study that was terminated before completion, run by Philips Respironics. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01241604, a NA study, was terminated before completion, sponsored by Philips Respironics.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study is being undertaken to collect data from Respironics, Inc's BiPAP autoSV3 and compare with data from Respironics, Inc's BiPAP S/T device, to confirm that the algorithms in the BiPAP autoSV3 device can safely and effectively treat participants experiencing Comp SAS no worse than the BiPAP S/T device. This will be determined using a comparative, randomized design with the participants blinded to the therapy. Additionally, attempts will be made to blind the central scorer(s) with respect to which device is in use.
Primary Outcome
The number of apneas and hypopneas per hour of sleep.
Interventions
- DEVICE BiPAP S/T
- DEVICE BiPAP Auto SV3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-07 |
| Phase | NA |
Why NCT01241604 stopped before completion
NCT01241604 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which BiPAP S/T is the first listed.
NCT01241604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01241604 about?
NCT01241604 is a clinical study titled "Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device Compared to BiPAP S/T Device". This study is being undertaken to collect data from Respironics, Inc's BiPAP autoSV3 and compare with data from Respironics, Inc's BiPAP S/T device, to confirm that the algorithms in the BiPAP autoSV3 device can safely and effectively treat participants experiencing Comp SAS no worse than the BiPAP ...
What is the current status of trial NCT01241604?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2009-01. Estimated completion is 2009-07.
What interventions are being tested in trial NCT01241604?
The interventions under investigation include: BiPAP S/T (DEVICE), BiPAP Auto SV3 (DEVICE).
Who is sponsoring clinical trial NCT01241604?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01241604's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia